Per-Göran Gillberg
Direktor/Vorstandsmitglied bei ALZINOVA AB
Aktive Positionen von Per-Göran Gillberg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALZINOVA AB | Direktor/Vorstandsmitglied | 01.01.2020 | - |
Independent Dir/Board Member | 01.01.2020 | - | |
DICOT AB | Direktor/Vorstandsmitglied | 27.05.2021 | - |
Independent Dir/Board Member | 27.05.2021 | - | |
Albireo AB
Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Gründer | 01.01.1998 | - |
Corporate Officer/Principal | 01.01.1998 | - |
Karriereverlauf von Per-Göran Gillberg
Ehemalige bekannte Positionen von Per-Göran Gillberg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALBIREO PHARMA, INC. | Corporate Officer/Principal | - | - |
ALBIREO PHARMA, INC. | Gründer | 08.12.2003 | - |
Corporate Officer/Principal | 08.12.2003 | - | |
Karolinska Institutet | Direktor/Vorstandsmitglied | - | - |
Pharmacia AB | Corporate Officer/Principal | - | - |
Pharmacia & Upjohn, Inc. | Corporate Officer/Principal | - | - |
KABI-AM | Corporate Officer/Principal | - | - |
░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Per-Göran Gillberg
University of Uppsala | Doctorate Degree |
Statistik
International
Schweden | 7 |
Vereinigte Staaten | 4 |
Vereinigtes Königreich | 3 |
Operativ
Corporate Officer/Principal | 8 |
Director/Board Member | 3 |
Founder | 2 |
Sektoral
Health Technology | 9 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ASTRAZENECA PLC | Health Technology |
DICOT AB | Health Technology |
ALZINOVA AB | Health Technology |
Private Unternehmen | 6 |
---|---|
Pharmacia & Upjohn, Inc. | Health Technology |
Pharmacia AB | Health Technology |
KABI-AM | Consumer Services |
Albireo Ltd.
Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Health Technology |
Albireo AB
Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Health Technology |
Albireo Pharma, Inc.
Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Per-Göran Gillberg
- Erfahrung